Skip to main content
FinSpry Logo
FinSpry
BLRX logo
BLRX
(NASDAQ)
BioLineRx Ltd.
$2.86-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BioLineRx (BLRX) Stock Price & Financial Analysis

BioLineRx Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.82 - $3.04
52-Week High$4.69
52-Week Low$2.15
Open$2.82
Volume8.02K
Average Volume (3M)21.95K
Market Cap12.68M
Shares Outstanding4.43M
Price to Sales (P/S)9.04
Price to Book (P/B)0.76
EV/EBITDA-2.81
Revenue (TTM)1.40M
Net Income (TTM)-8.88M
Free Cash Flow (TTM)-7.79M
EPS (TTM)$-2.13
Profit Margin-633.59%
Operating Margin-777.46%
Return on Equity (ROE)-53.28%
Debt to Equity0.54
50-Day MA$3.13
200-Day MA$3.04
52-Week Change-37.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BioLineRx

What is the current stock price for BLRX?

As of the latest trading session, BLRX stock trades at $2.86. The 52-week range is $2.15–$4.69, with a day range of $2.82–$3.04.

What is the P/E ratio for BLRX?

The P/E ratio (Price-to-Earnings) for BLRX is shown in the Key Statistics section. This valuation metric helps compare BioLineRx Ltd. to industry peers.

Does BLRX pay dividends?

BioLineRx does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLRX?

Analyst ratings and recommendations for BLRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BLRX?

BioLineRx's market capitalization is $12.7M, classifying it as a micro-cap company. BioLineRx operates in the Healthcare sector within the Biotechnology industry.